BRIEF published on 11/04/2026 at 10:50, 2 days 9 hours ago BRAIN Biotech and Syngenta Collaborate on Sustainable Farming Innovations Biotechnology Sustainable Farming Agricultural Innovation Synthetic Biology Microbial Strain
PRESS RELEASE published on 11/04/2026 at 10:45, 2 days 9 hours ago BRAIN Biotech and Syngenta form strategic cooperation applying synthetic biology to drive innovations in sustainable farming solutions
BRIEF published on 09/09/2026 at 13:25, 1 month 27 days ago BRAIN Biotech AG Secures EUR 11.51 Million Milestone Payment Financial Position BRAIN Biotech AG Milestone Payment Deucrictibant Royalty Pharma
PRESS RELEASE published on 09/09/2026 at 13:20, 1 month 27 days ago BRAIN Biotech AG Receives EUR 11.51 Million Major Milestone Payment from Royalty Pharma BRAIN Biotech AG receives EUR 11.51 million milestone payment from Royalty Pharma, enhancing financial position. Expecting additional future milestone payments. CFO sees positive developments Financial Position BRAIN Biotech AG Milestone Payment Royalty Pharma Future Milestones
BRIEF published on 09/09/2026 at 13:17, 1 month 27 days ago BRAIN Biotech AG Secures EUR 11.51 Million from Royalty Pharma Financial Impact BRAIN Biotech Milestone Payment Deucrictibant Royalty Pharma
PRESS RELEASE published on 09/09/2026 at 13:12, 1 month 27 days ago EQS-Adhoc: BRAIN Biotech AG Receives EUR 11.51 Million Major Milestone Payment from Royalty Pharma BRAIN Biotech AG receives EUR 11.51 million milestone payment from Royalty Pharma for pharma compound development Development BRAIN Biotech AG Milestone Payment Royalty Pharma Pharma Compound
BRIEF published on 08/27/2026 at 07:35, 2 months 10 days ago BRAIN Biotech Reports 9M Results, Targets Break-even EBITDA Financial Results Revenue Forecast Revenue Decline EBITDA Target CEO Commentary
PRESS RELEASE published on 08/27/2026 at 07:30, 2 months 10 days ago BRAIN Biotech reports its 9M results and continues to target a break-even adjusted Group-EBITDA BRAIN Biotech reports 9M results targeting break-even adjusted Group-EBITDA. BRAINBioIncubator forecast raised, BRAINBiocatalysts lowered. Detailed financial data and outlook included Adjusted EBITDA Financial Forecast Revenue Performance BRAIN Biotech 9M Results
BRIEF published on 07/29/2026 at 14:45, 3 months 8 days ago Dr. Sven K. Weber Appointed CEO of BRAIN Biotech AG CEO Appointment BRAIN Biotech AG Sven K. Weber Adriaan Moelker Enzyme Sector
PRESS RELEASE published on 07/29/2026 at 14:40, 3 months 8 days ago Dr. Sven K. Weber Succeeds Adriaan Moelker as CEO of BRAIN Biotech AG Dr. Sven K. Weber succeeds Adriaan Moelker as CEO of BRAIN Biotech AG. Transition effective from October 1, 2026. Moelker to retire after leading for 6 years Leadership Transition BRAIN Biotech AG CEO Succession Dr. Sven K. Weber Adriaan Moelker
Published on 11/06/2026 at 13:00, 7 hours 40 minutes ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 8 hours 10 minutes ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 8 hours 10 minutes ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 05:15, 15 hours 25 minutes ago Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins
Published on 11/06/2026 at 20:15, 25 minutes ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:15, 1 hour 25 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 1 hour 40 minutes ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 2 hours 8 minutes ago EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 18:00, 2 hours 40 minutes ago ARVERNE GROUP: Number shares and voting rights
Published on 11/06/2026 at 18:00, 2 hours 40 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 11/06/2026 at 17:54, 2 hours 46 minutes ago Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 3 hours 5 minutes ago Disclosure of the number of shares and the total number of voting rights as of October 31, 2026
